Ashraf Omar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ashraf Omar has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Rajat Walia
Department of Thoracic Disease and Transplantation, Norton Thoracic Institute, Phoenix, USA
5 shared publications - Ashwini Arjuna
Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USA
4 shared publications - Deepika Razia
Department of Medicine, Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, Arizona
4 shared publications - Sofya Tokman
Division of Transplant Pulmonology Norton Thoracic Institute Dignity Health St. Joseph's Hospital and Medical Center Phoenix Arizona USA
4 shared publications - Hesham Mohamed
Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States
2 shared publications - Ross M. Bremner
Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, USA
2 shared publications
Latest Publications
- 16 October 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (3) , 442-452
Evolving impact of the COVID-19 pandemic on lung transplant recipients: A single-center experience
- 16 October 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (3) , 442-452
Evolving impact of the COVID-19 pandemic on lung transplant recipients: A single-center experience
- Open Access
- 1 March 2023
- Published by LIDSEN Publishing Inc in OBM Transplantation
- Vol. 07 (01) , 1-13
Impact of Sex and Age at Lung Transplantation on Long-Term Survival of Patients with Cystic Fibrosis
Careful selection of lung transplant (LT) recipients with cystic fibrosis (CF) may improve outcomes; therefore, we studied the impact of sex and age at the time of LT on long-term survival of patients with CF. LT recipients with CF who received post-LT care at our center between July 1, 2007 and April 30, 2021 were included. The primary outcome was death or retransplantation. Cox proportional hazard analysis and the Kaplan-Meier method were used. Of 59 included LT recipients, the median age at first LT was 28 (22, 36) years, 36 (61%) patients were ≥25 years old, and 30 (51%) were male. At the end of the study, 21 (36%) had died and 17 (29%) had required retransplantation, with a median lung allograft survival of 33.4 (16.1, 66.4) months. The remaining 21 patients (36%) were alive at a median of 68 (28, 112) months after primary LT. The probability of survival of male patients trended higher than that of female patients (66.7% vs 44.8%, p = 0.069). Compared to age < 25 years at LT, age ≥ 25 years was associated with a significantly higher probability of survival (63.9% vs 43.5%, p = 0.047). LT recipients with CF aged ≥ 25 years at LT had significantly higher survival than younger patients, and survival trended higher for male recipients compared to female recipients. These results identify an at-risk population of LT recipients who may warrant closer attention after LT. Large multicenter trials with adequate power are needed.
- 1 March 2023
- Published by LIDSEN Publishing Inc in OBM Transplantation
- Vol. 07 (01) , 1-13
Open AccessImpact of Sex and Age at Lung Transplantation on Long-Term Survival of Patients with Cystic Fibrosis
Careful selection of lung transplant (LT) recipients with cystic fibrosis (CF) may improve outcomes; therefore, we studied the impact of sex and age at the time of LT on long-term survival of patients with CF. LT recipients with CF who received post-LT care at our center between July 1, 2007 and April 30, 2021 were included. The primary outcome was death or retransplantation. Cox proportional hazard analysis and the Kaplan-Meier method were used. Of 59 included LT recipients, the median age at first LT was 28 (22, 36) years, 36 (61%) patients were ≥25 years old, and 30 (51%) were male. At the end of the study, 21 (36%) had died and 17 (29%) had required retransplantation, with a median lung allograft survival of 33.4 (16.1, 66.4) months. The remaining 21 patients (36%) were alive at a median of 68 (28, 112) months after primary LT. The probability of survival of male patients trended higher than that of female patients (66.7% vs 44.8%, p = 0.069). Compared to age < 25 years at LT, age ≥ 25 years was associated with a significantly higher probability of survival (63.9% vs 43.5%, p = 0.047). LT recipients with CF aged ≥ 25 years at LT had significantly higher survival than younger patients, and survival trended higher for male recipients compared to female recipients. These results identify an at-risk population of LT recipients who may warrant closer attention after LT. Large multicenter trials with adequate power are needed.
- Open Access
- 3 March 2022
- Published by Wiley in Journal of Transplantation
- Vol. 2022, 1-8
Orthostatic Hypotension and Concurrent Autonomic Dysfunction: A Novel Complication of Lung Transplantation
Background. Persistent orthostatic hypotension (OH) is a lesser-known complication of lung transplantation (LTx). In this retrospective case series, we describe the clinical manifestations, complications, and treatment of persistent OH in 13 LTx recipients. Methods. We identified LTx recipients who underwent transplantation between March 1, 2018, and March 31, 2020, with persistent symptomatic OH and retrospectively queried the records for clinical information. Results. Thirteen patients were included in the analysis, 9 (69) had underlying pulmonary fibrosis, and 12 (92) were male. The median age, height, and body mass index at LTx were 68 years, 70 inches, and 27kg/m2, respectively. Six (46) patients were deceased at the time of chart abstraction with a median (IQR) posttransplant survival of 12.6 months (6, 21); the 7 remaining living patients were a median of 19.6 months (18, 32) posttransplant. Signs and symptoms of OH developed a median of 60 (7, 75) days after transplant. Patients were treated with pharmacological agents and underwent extensive physical therapy. Most patients required inpatient rehabilitation (n=10, 77), and patients commonly developed comorbid conditions including weight loss, renal insufficiency with eGFR n=13, 100), gastroparesis (n=7, 54), and tachycardia-bradycardia syndrome (n=2, 15). Falls were common (n=10, 77). The incidence of OH in LTx recipients at our center during the study period was 5.6 (13/234). Conclusions. Persistent OH is a lesser-known complication of LTx that impacts posttransplant rehabilitation and may lead to comorbidities and shortened survival. In addition, most LTx recipients with OH at our center were tall, thin men with underlying pulmonary fibrosis, which may offer an opportunity to instate pretransplant OH screening of at-risk patients.
- 3 March 2022
- Published by Wiley in Journal of Transplantation
- Vol. 2022, 1-8
Open AccessOrthostatic Hypotension and Concurrent Autonomic Dysfunction: A Novel Complication of Lung Transplantation
Background. Persistent orthostatic hypotension (OH) is a lesser-known complication of lung transplantation (LTx). In this retrospective case series, we describe the clinical manifestations, complications, and treatment of persistent OH in 13 LTx recipients. Methods. We identified LTx recipients who underwent transplantation between March 1, 2018, and March 31, 2020, with persistent symptomatic OH and retrospectively queried the records for clinical information. Results. Thirteen patients were included in the analysis, 9 (69) had underlying pulmonary fibrosis, and 12 (92) were male. The median age, height, and body mass index at LTx were 68 years, 70 inches, and 27kg/m2, respectively. Six (46) patients were deceased at the time of chart abstraction with a median (IQR) posttransplant survival of 12.6 months (6, 21); the 7 remaining living patients were a median of 19.6 months (18, 32) posttransplant. Signs and symptoms of OH developed a median of 60 (7, 75) days after transplant. Patients were treated with pharmacological agents and underwent extensive physical therapy. Most patients required inpatient rehabilitation (n=10, 77), and patients commonly developed comorbid conditions including weight loss, renal insufficiency with eGFR n=13, 100), gastroparesis (n=7, 54), and tachycardia-bradycardia syndrome (n=2, 15). Falls were common (n=10, 77). The incidence of OH in LTx recipients at our center during the study period was 5.6 (13/234). Conclusions. Persistent OH is a lesser-known complication of LTx that impacts posttransplant rehabilitation and may lead to comorbidities and shortened survival. In addition, most LTx recipients with OH at our center were tall, thin men with underlying pulmonary fibrosis, which may offer an opportunity to instate pretransplant OH screening of at-risk patients.
- Open Access
- 1 April 2021
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 40 (4) , S502
Two Cases of Spontaneous Bleeding in Lung Transplant Recipients Treated with Systemic Anticoagulation for COVID-19
- 1 April 2021
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 40 (4) , S502
Open AccessTwo Cases of Spontaneous Bleeding in Lung Transplant Recipients Treated with Systemic Anticoagulation for COVID-19